Summary

The dental bone graft substitutes market is projected to reach USD 2.04 billion by 2031 from USD 1.40 billion in 2026, at a CAGR of 6.5% during the forecast period. The dental bone graft substitutes industry is largely driven by a rising prevalence of dental diseases, such as tooth loss, periodontitis, and maxillofacial defects. This surge has increased the demand for effective bone regeneration solutions. Additionally, the growing popularity of dental implants and advanced restorative materials has significantly increased demand for high-quality graft materials. Innovations in graft substitutes, such as xenografts, allografts, and synthetic alternatives, have led to better clinical outcomes, greater predictability, and greater convenience, making them the preferred choice among dental practitioners. Furthermore, the growing awareness of oral health among patients and clinicians, along with the expansion of dental facilities and specialized surgical services, has positively impacted market growth. The combination of clinical needs, technological advancements, and heightened patient awareness is driving the global demand for dental bone graft substitutes. “By application, resins are expected to hold the largest market share in the dental bone graft substitutes market.” In the dental bone graft substitutes market, the socket preservation segment holds the largest share. This is due to its frequent use during the postoperative period following tooth extractions and its crucial role in preserving alveolar bone stock. After a tooth extraction, rapid bone resorption may eventually necessitate the placement of dental implants. As a result, socket preservation is a viable option within the dental bone graft substitutes market. Dental bone graft substitutes are typically placed immediately after an extraction to stabilize the socket and promote bone formation. Tooth extractions are quite common worldwide for various reasons, including dental caries, periodontal disease, and trauma, underscoring the importance of the socket preservation market. This segment is widely appreciated in the industry for its ease of application and predictable outcomes, making it a favored choice among dentists across specialties. “By end user, hospitals are expected to hold the largest share in the dental bone graft substitutes market.” In the dental bone graft substitutes market, hospitals hold a significant market share. This is largely due to their established clinical settings and ability to treat a large number of patients while performing various complex dental and oral surgeries. For example, hospitals are equipped to handle cases requiring dental and jaw reconstruction procedures that involve bone grafting substitutes. These cases include dental implant procedures, periodontal treatments, and jaw rebuilding or reconstruction surgeries. Bone graft substitutes are essential for all dental and jaw surgeries, given the high technical and clinical demands of these procedures. Additionally, dental and jaw departments in hospitals are well-established and efficiently managed, thereby enhancing their capacity to use these substitutes effectively. Consequently, hospitals are considered the primary end-user facilities for dental bone substitutes. “The US is expected to grow at the highest CAGR in the North American dental bone graft substitutes market during the forecast period.” The dental bone graft substitutes market in North America is expected to grow at the highest rate in the US, driven by several key factors. A growing aging population and an increasing prevalence of age-related dental issues, such as tooth loss and periodontitis, are driving the demand for dental substitutes in the country. Additionally, the presence of a favorable dental care infrastructure and a greater acceptance of innovative dental technologies are contributing to the growth of dental bone graft substitutes in America. Furthermore, the rising use of dental procedures like dental implantology, along with increasing awareness of dental and periodontal health among dental surgeons and conscientious consumers, is also supporting the expansion of this market. Collectively, these factors have positioned the US as the leading market for dental bone graft substitutes in North America. A breakdown of the primary participants (on the supply side) for the dental bone graft substitutes market referenced in this report is provided below: ・ By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%) ・ By Designation: C-level Executives (45%), Directors (35%), and Others (20%) ・ By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%) The prominent players in the dental bone graft substitutes market are Dentsply Sirona (US), Envista (US), Johnson & Johnson (US), Institut Straumann AG (Switzerland), Medtronic (Ireland), Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical (US), and LifeNet Health (US). Research Coverage: The report provides an analysis of the dental bone graft substitutes market, focusing on estimating its size and future growth potential across segments such as product, application, type, mechanism, end user, and region. Additionally, the report features a competitive analysis of key players in the market, including their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report The report provides valuable insights for both market leaders and new entrants in the dental bone graft substitutes market, offering the most accurate revenue estimates. It helps stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, giving stakeholders a comprehensive understanding of current market trends. This report provides insights into the following pointers: ・ Analysis of key drivers (growing market for dental tourism in emerging countries, increasing disposable income in developing counties, rising cases of dental caries and subsequent increase in tooth repair procedures, and changing demographics), restraints (lack of proper reimbursement scenario, stringent regulations pertaining to medical devices used in dentistry, and dearth of trained dental practitioners), opportunities (increasing demand from customers and rising inclination towards cosmetic dentistry, low penetration rates for dental bone graft substitutes, consolidation of dental practices and rising DSO activity, and growing demand for bone graft substitutes from emerging markets), and challenges (pricing pressure faced by prominent market players). ・ Market Penetration: It includes extensive information on the products offered by the major players in the global dental bone graft substitutes market. The report includes various segments, such as products, applications, types, mechanisms, end users, and regions. ・ Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental bone graft substitutes market. ・ Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, mechanism, application, end user, and region. ・ Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global dental bone graft substitutes market. ・ Competitive Assessment: A comprehensive assessment of market shares, growth strategies, product offerings, and capabilities of key competitors in the global dental bone graft substitutes market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKET SEGMENTATION 26
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.4 KEY STAKEHOLDERS 28
1.5 SUMMARY OF CHANGES 28
2 EXECUTIVE SUMMARY 30
2.1 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND MARKET DEVELOPMENTS 32
2.2 DISRUPTIVE TRENDS SHAPING MARKET 33
2.3 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 34
2.4 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 35
3 PREMIUM INSIGHTS 36
3.1 DENTAL BONE GRAFT SUBSTITUTES MARKET OVERVIEW 36
3.2 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE AND COUNTRY, (2025) 37
3.3 DENTAL BONE GRAFT SUBSTITUTES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38
3.4 DENTAL BONE GRAFT SUBSTITUTES MARKET, REGIONAL MIX, 2024−2031 39
3.5 DENTAL BONE GRAFT SUBSTITUTES MARKET: EMERGING VS. DEVELOPED MARKETS 39
4 MARKET OVERVIEW 40
4.1 INTRODUCTION 40
4.2 MARKET DYNAMICS 40
4.2.1 DRIVERS 41
4.2.1.1 Growth of dental tourism in emerging countries 41
4.2.1.2 Increasing disposable income in developing countries 41
4.2.1.3 Rising cases of dental caries and subsequent increase in tooth repair procedures 42
4.2.1.4 Changing demographics 42
4.2.2 RESTRAINTS 43
4.2.2.1 Lack of proper reimbursement scenario 43
4.2.2.2 Stringent regulations pertaining to medical devices used in dentistry 43
4.2.2.3 Dearth of trained dental practitioners 43
 
4.2.3 OPPORTUNITIES 44
4.2.3.1 Increasing demand from customers and rising inclination toward cosmetic dentistry 44
4.2.3.2 Consolidation of dental practices and rising DSO activity 44
4.2.3.3 Growing demand for bone graft substitutes from emerging markets 45
4.2.4 CHALLENGES 45
4.2.4.1 Pricing pressure faced by prominent market players 45
4.3 UNMET NEEDS AND WHITE SPACES 45
4.3.1 UNMET NEEDS 45
4.3.2 WHITE SPACE OPPORTUNITIES 46
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 46
4.4.1 INTERCONNECTED MARKETS 46
4.4.2 CROSS-SECTOR OPPORTUNITIES 47
4.5 STRATEGIC MOVES BY TIER- 1/2/3 PLAYERS 47
5 INDUSTRY TRENDS 49
5.1 PORTER’S FIVE FORCES ANALYSIS 49
5.1.1 THREAT OF NEW ENTRANTS 50
5.1.2 THREAT OF SUBSTITUTES 50
5.1.3 BARGAINING POWER OF SUPPLIERS 50
5.1.4 BARGAINING POWER OF BUYERS 50
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 50
5.2 MACROECONOMIC OUTLOOK 51
5.2.1 INTRODUCTION 51
5.2.2 GDP TRENDS AND FORECAST 51
5.2.3 TRENDS IN DENTAL BONE GRAFT SUBSTITUTES MARKET 53
5.3 VALUE CHAIN ANALYSIS 53
5.4 SUPPLY CHAIN ANALYSIS 54
5.5 ECOSYSTEM ANALYSIS 56
5.6 PRICING ANALYSIS 57
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025 57
5.6.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 58
5.7 TRADE ANALYSIS 59
5.7.1 IMPORT DATA FOR HS CODE 3006 59
5.7.2 EXPORT DATA FOR HS CODE 3006 60
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 60
5.9 CASE STUDY ANALYSIS 61
5.9.1 CASE STUDY 1: SINUS FLOOR ELEVATION AND RIDGE AUGMENTATION USING GEISTLICH BIO-OSS 61
5.9.2 CASE STUDY 2: RIDGE PRESERVATION AND BONE REGENERATION USING NOVABONE DENTAL PUTTY 61
5.10 INVESTMENT AND FUNDING SCENARIO 62
 
5.11 IMPACT OF US TARIFFS—DENTAL BONE GRAFT SUBSTITUTES MARKET 62
5.11.1 INTRODUCTION 62
5.11.2 KEY TARIFF RATES 64
5.11.3 PRICE IMPACT ANALYSIS 64
5.11.4 IMPACT ON COUNTRIES/REGIONS 65
5.11.4.1 US 65
5.11.4.2 Europe 65
5.11.4.3 Asia Pacific 65
5.11.5 IMPACT ON END-USER INDUSTRIES 65
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 66
6.1 KEY EMERGING TECHNOLOGIES 66
6.1.1 GROWTH FACTOR-ENHANCED BONE GRAFTS 66
6.1.2 SYNTHETIC BIOMIMETIC BONE GRAFT MATERIALS 66
6.1.3 GUIDED BONE REGENERATION TECHNOLOGY 66
6.2 COMPLEMENTARY TECHNOLOGIES 67
6.2.1 BARRIER MEMBRANE TECHNOLOGY 67
6.2.2 TITANIUM MESH TECHNOLOGY 67
6.3 ADJACENT TECHNOLOGIES 67
6.3.1 COMPUTER-GUIDED IMPLANT PLANNING SOFTWARE 67
6.3.2 CONE-BEAM COMPUTED TOMOGRAPHY 67
6.4 TECHNOLOGY/PRODUCT ROADMAP 68
6.4.1 SHORT-TERM | RECENT TECHNOLOGIES| FOUNDATION & EARLY COMMERCIALIZATION 68
6.4.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 69
6.4.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 70
6.5 PATENT ANALYSIS 71
6.5.1 PATENT PUBLICATION TRENDS 71
6.5.2 JURISDICTION ANALYSIS 71
6.6 IMPACT OF AI/GEN AI ON DENTAL BONE GRAFT SUBSTITUTES MARKET 74
6.6.1 TOP USE CASES AND MARKET POTENTIAL 75
6.6.2 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 75
6.6.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN DENTAL BONE GRAFT SUBSTITUTES MARKET 76
6.7 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 76
6.7.1 INSTITUT STRAUMANN/BOTISS: CAD/CAM CUSTOMIZED BONE BLOCK FOR RIDGE AUGMENTATION 76
6.7.2 DENTSPLY SIRONA: AI-POWERED DIGITAL WORKFLOW WITH SYMBIOS REGENERATIVE PORTFOLIO 76
 
7 REGULATORY LANDSCAPE 77
7.1 REGIONAL REGULATIONS AND COMPLIANCE 77
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
7.1.2 INDUSTRY STANDARDS 80
7.1.2.1 North America 80
7.1.2.1.1 US 80
7.1.2.1.2 Canada 81
7.1.2.2 Europe 81
7.1.2.3 Asia Pacific 81
7.1.2.3.1 China 81
7.1.2.3.2 Japan 82
7.1.2.4 Latin America 82
7.1.2.4.1 Brazil 82
7.1.2.4.2 Mexico 82
7.1.2.5 Middle East 82
7.1.2.6 Africa 83
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 83
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 85
8.1 DECISION-MAKING PROCESS 85
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 86
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 86
8.2.2 BUYING CRITERIA 87
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 87
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 88
9 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE 90
9.1 INTRODUCTION 91
9.2 SYNTHETIC BONE GRAFTS 92
9.2.1 INCREASING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF SYNTHETIC BONE GRAFTS 92
9.3 XENOGRAFTS 93
9.3.1 RISING ADOPTION OF ADVANCED XENOGRAFT MATERIALS SUPPORTED BY TECHNOLOGICAL IMPROVEMENTS TO DRIVE MARKET 93
9.4 ALLOGRAFTS 94
9.4.1 GROWING PREFERENCE FOR ALLOGRAFTS DUE TO REDUCED SURGICAL BURDEN 94
9.4.2 DEMINERALIZED BONE MATRIX 96
9.4.2.1 Demineralized bone possesses more osteoinductive properties 96
9.4.3 OTHER ALLOGRAFTS 97
9.5 OTHER DENTAL BONE GRAFT SUBSTITUTES 98
10 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION 100
10.1 INTRODUCTION 101
10.2 SOCKET PRESERVATION 101
10.2.1 SOCKET PRESERVATION REDUCES BONE LOSS AFTER TOOTH EXTRACTION 101
10.3 RIDGE AUGMENTATION 103
10.3.1 RIDGE AUGMENTATION RECREATES NATURAL CONTOUR OF GUMS AND JAW 103
10.4 PERIODONTAL DEFECT REGENERATION 104
10.4.1 CHANGES IN LIFESTYLE AND EATING HABITS TO LEAD TO USE OF DENTAL BONE GRAFT SUBSTITUTES FOR PERIODONTAL DEFECT REGENERATION 104
10.5 IMPLANT BONE REGENERATION 105
10.5.1 UTILIZATION OF GUIDED BONE REGENERATION MEMBRANES FACILITATES HEALING OF GRAFTED MATERIAL 105
10.6 SINUS LIFT 106
10.6.1 SINUS AUGMENTATION RAISES SINUS FLOOR AND DEVELOPS BONE FOR PLACEMENT OF DENTAL IMPLANTS 106
11 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM 108
11.1 INTRODUCTION 109
11.2 OSTEOCONDUCTION 109
11.2.1 OSTEOCONDUCTION SERVES AS A SCAFFOLD FOR BONE CELLS TO ATTACH, MIGRATE, GROW, AND DIVIDE 109
11.3 OSTEOINDUCTION 110
11.3.1 OSTEOINDUCTION FACILITATES BONE HEALING PROCESS 110
11.4 OSTEOPROMOTION 111
11.4.1 OSTEOPROMOTION INVOLVES ENHANCEMENT OF OSTEOINDUCTION WITHOUT POSSESSION OF OSTEOINDUCTIVE PROPERTIES 111
11.5 OSTEOGENESIS 113
11.5.1 OSTEOGENESIS PLAYS CRUCIAL ROLE IN FACILITATING SUCCESSFUL BONE REGENERATION AND REPAIR 113
12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER 115
12.1 INTRODUCTION 116
12.2 DENTAL HOSPITALS 116
12.2.1 INCREASING NUMBER OF COSMETIC DENTISTRY PROCEDURES ACROSS DENTAL HOSPITALS TO DRIVE MARKET GROWTH 116
12.3 DENTAL CLINICS 117
12.3.1 EASY ACCESS AND AVAILABILITY OF HIGH-QUALITY SERVICES TO DRIVE MARKET GROWTH 117
12.4 OTHER END USERS 119
 
13 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY REGION 120
13.1 INTRODUCTION 121
13.2 NORTH AMERICA 122
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 122
13.2.2 US 126
13.2.2.1 Increasing patient awareness about advantages of dental bone graft substitutes over traditional treatments to boost growth 126
13.2.3 CANADA 128
13.2.3.1 Rising geriatric population to propel market expansion 128
13.3 EUROPE 130
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 130
13.3.2 GERMANY 133
13.3.2.1 Country’s robust health insurance system to drive popularity of dental bone graft substitutes 133
13.3.3 UK 135
13.3.3.1 Preference for costly procedures due to the availability of reimbursement facilities to lead to potential growth 135
13.3.4 FRANCE 137
13.3.4.1 Rising awareness among people regarding benefits of dental bone graft substitutes and presence of major players to drive growth 137
13.3.5 ITALY 139
13.3.5.1 Intensive R&D and use of sophisticated materials to manufacture advanced products to propel market 139
13.3.6 SPAIN 141
13.3.6.1 Government initiatives to provide dental cover to people to boost market 141
13.3.7 REST OF EUROPE 144
13.4 ASIA PACIFIC 146
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 146
13.4.2 JAPAN 149
13.4.2.1 Increasing awareness, availability of reimbursement, and growing income levels to offer growth opportunities for market players 149
13.4.3 CHINA 152
13.4.3.1 Growing geriatric population, economic boom, and increasing per capita income to propel growth 152
13.4.4 INDIA 154
13.4.4.1 Diverse, lucrative opportunities offered to dental product and service providers to ensure adequate market progress 154
13.4.5 AUSTRALIA 157
13.4.5.1 Popularity of xenograft and allograft to open new opportunities for growth of market players 157
13.4.6 SOUTH KOREA 159
13.4.6.1 Rising geriatric population and medical tourism to drive market 159
13.4.7 REST OF ASIA PACIFIC 162
 
13.5 LATIN AMERICA 164
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 164
13.5.2 BRAZIL 167
13.5.2.1 Improving healthcare infrastructure and rising investments by leading players to spur demand 167
13.5.3 MEXICO 169
13.5.3.1 Rising medical tourism to support market growth 169
13.5.4 ARGENTINA 171
13.5.4.1 Growing demand for personalized dentistry to spur market demand 171
13.5.5 REST OF LATIN AMERICA 173
13.6 MIDDLE EAST & AFRICA 175
13.6.1 GROWING INVESTMENTS IN DIGITAL HEALTHCARE INDUSTRY TO BOOST DEMAND FOR DENTAL BONE GRAFT SUBSTITUTES 175
13.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 175
13.7 GCC COUNTRIES 178
13.7.1 INCREASING DEMAND FOR HEALTH SERVICES DUE TO POPULATION GROWTH TO DRIVE MARKET FOR DENTAL BONE GRAFT SUBSTITUTES 178
13.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 178
14 COMPETITIVE LANDSCAPE 181
14.1 INTRODUCTION 181
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 181
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET 181
14.3 REVENUE ANALYSIS 183
14.4 MARKET SHARE ANALYSIS (2025) 183
14.5 COMPANY VALUATION AND FINANCIAL METRICS 185
14.5.1 COMPANY VALUATION 185
14.5.2 FINANCIAL METRICS 186
14.6 BRAND/PRODUCT COMPARISON 187
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 188
14.7.1 STARS 188
14.7.2 EMERGING LEADERS 188
14.7.3 PERVASIVE PLAYERS 188
14.7.4 PARTICIPANTS 188
14.7.5 COMPANY FOOTPRINT (KEY PLAYERS), 2025 190
14.7.5.1 Company footprint 190
14.7.5.2 Region footprint 191
14.7.5.3 Type footprint 192
14.7.5.4 APPLICATION Footprint 193
14.7.5.5 Mechanism Footprint 194
14.7.5.6 End-user footprint 195
 
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2025) 197
14.8.1 PROGRESSIVE COMPANIES 197
14.8.2 RESPONSIVE COMPANIES 197
14.8.3 DYNAMIC COMPANIES 197
14.8.4 STARTING BLOCKS 197
14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 199
14.8.5.1 Detailed list of key startups/SMEs 199
14.8.5.2 Competitive benchmarking of startups/SMEs 199
14.9 R&D EXPENDITURE OF KEY PLAYERS (DENTAL BONE GRAFT SUBSTITUTES MARKET) 200
14.10 COMPETITIVE SCENARIO 200
14.10.1 PRODUCT LAUNCHES AND APPROVALS 200
14.10.2 DEALS 201
14.10.3 EXPANSIONS 202
14.10.4 OTHER DEVELOPMENTS 203
15 COMPANY PROFILES 204
15.1 KEY PLAYERS 204
15.1.1 DENTSPLY SIRONA INC. 204
15.1.1.1 Business overview 204
15.1.1.2 Products offered 205
15.1.1.3 Recent developments 206
15.1.1.3.1 Product launches and approvals 206
15.1.1.3.2 Deals 206
15.1.1.4 MnM view 207
15.1.1.4.1 Right to win 207
15.1.1.4.2 Strategic choices 207
15.1.1.4.3 Weaknesses and competitive threats 207
15.1.2 ENVISTA 208
15.1.2.1 Business overview 208
15.1.2.2 Products offered 209
15.1.2.3 Recent developments 210
15.1.2.3.1 Deals 210
15.1.2.3.2 Expansions 211
15.1.2.4 MnM view 211
15.1.2.4.1 Right to win 211
15.1.2.4.2 Strategic choices 211
15.1.2.4.3 Weaknesses and competitive threats 211
 
15.1.3 INSTITUT STRAUMANN AG 212
15.1.3.1 Business overview 212
15.1.3.2 Products offered 213
15.1.3.3 Recent developments 214
15.1.3.3.1 Deals 214
15.1.3.3.2 Expansions 215
15.1.3.4 MnM view 216
15.1.3.4.1 Right to win 216
15.1.3.4.2 Strategic choices 216
15.1.3.4.3 Weaknesses and competitive threats 216
15.1.4 ADVANCED MEDICAL SOLUTIONS GROUP PLC 217
15.1.4.1 Business overview 217
15.1.4.2 Products offered 218
15.1.4.3 Recent developments 219
15.1.4.3.1 Deals 219
15.1.5 ZIMVIE INC. 220
15.1.5.1 Business overview 220
15.1.5.2 Products offered 221
15.1.5.3 Recent developments 222
15.1.5.3.1 Product launches and approvals 222
15.1.5.3.2 Deals 222
15.1.6 HENRY SCHEIN, INC. 223
15.1.6.1 Business overview 223
15.1.6.2 Products offered 224
15.1.6.3 Recent developments 225
15.1.6.3.1 Deals 225
15.1.6.3.2 Expansions 226
15.1.6.4 MnM view 226
15.1.6.4.1 Right to win 226
15.1.6.4.2 Strategic choices 226
15.1.6.4.3 Weaknesses and competitive threats 226
15.1.7 EVERGEN (FORMERLY RTI SURGICAL) 227
15.1.7.1 Business overview 227
15.1.7.2 Products offered 227
15.1.7.3 Recent developments 228
15.1.7.3.1 Deals 228
15.1.7.3.2 Other developments 228
15.1.8 LIFENET HEALTH 229
15.1.8.1 Business overview 229
15.1.8.2 Products offered 229
15.1.8.3 Recent developments 230
15.1.8.3.1 Product launches and approvals 230
15.1.8.3.2 Deals 230
15.1.9 NOVABONE 231
15.1.9.1 Business overview 231
15.1.9.2 Products offered 231
15.1.9.3 Recent developments 232
15.1.9.3.1 Product launches and approvals 232
15.1.9.3.2 Deals 232
15.1.10 GEISTLICH PHARMA AG 233
15.1.10.1 Business overview 233
15.1.10.2 Products offered 233
15.1.10.3 Recent developments 234
15.1.10.3.1 Deals 234
15.1.10.3.2 Other developments 234
15.2 OTHER PLAYERS 235
15.2.1 BOTISS BIOMATERIALS GMBH 235
15.2.2 REGENITY 236
15.2.3 OSTEOGENIC BIOMEDICAL 237
15.2.4 HANNOX INTERNATIONAL CORP 238
15.2.5 KEYSTONE DENTAL GROUP 238
15.2.6 YOUNG INNOVATIONS INC 239
15.2.7 BEGO GMBH &CO.KG 240
15.2.8 TISSUE REGENIX GROUP 240
15.2.9 DENTIUM CO., LTD 241
15.2.10 MEDBONE 241
15.2.11 PURGO BIOLOGICS INC 242
15.2.12 REGEDENT AG 242
15.2.13 TECNOSS DENTAL SRL 243
15.2.14 SIGMAGRAFT BIOMATERIALS 244
15.2.15 CITAGENIX 245
16 RESEARCH METHODOLOGY 246
16.1 RESEARCH DATA 246
16.1.1 SECONDARY DATA 247
16.1.1.1 Key data from secondary sources 248
16.1.2 PRIMARY DATA 248
16.1.2.1 Key data from primary sources 249
16.1.2.2 Key industry insights 250
16.2 MARKET SIZE ESTIMATION 252
16.3 MARKET BREAKDOWN AND DATA TRIANGULATION 258
16.4 MARKET SHARE ESTIMATION 259
16.5 RESEARCH ASSUMPTIONS 259
 
16.6 RESEARCH LIMITATIONS 259
16.6.1 SCOPE-RELATED LIMITATIONS 259
16.6.2 METHODOLOGY-RELATED LIMITATIONS 260
16.7 RISK ASSESSMENT 260
17 APPENDIX 261
17.1 DISCUSSION GUIDE 261
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 264
17.3 CUSTOMIZATION OPTIONS 266
17.4 RELATED REPORTS 266
17.5 AUTHOR DETAILS 267

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES, 2018–2022 27
TABLE 2 DENTAL BONE GRAFT SUBSTITUTES MARKET: UNMET NEEDS 45
TABLE 3 DENTAL BONE GRAFT SUBSTITUTES MARKET: PORTER’S FIVE FORCES ANALYSIS 49
TABLE 4 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2021-2030 51
TABLE 5 AVERAGE SELLING PRICE TREND OF DENTAL BONE GRAFT SUBSTITUTES,
BY KEY PLAYER, 2023–2025 58
TABLE 6 AVERAGE SELLING PRICE TREND OF XENOGRAFTS, BY REGION, 2023–2025 58
TABLE 7 AVERAGE SELLING PRICE TREND OF ALLOGRAFTS, BY REGION, 2023–2025 59
TABLE 8 IMPORT DATA FOR DENTAL BONE GRAFT SUBSTITUTE PRODUCTS
(HS CODE 3006), BY COUNTRY, 2021–2025 (USD THOUSAND) 59
TABLE 9 EXPORT DATA FOR DENTAL BONE GRAFT SUBSTITUTE PRODUCTS
(HS CODE 3006), BY COUNTRY, 2021–2025 (USD THOUSAND) 60
TABLE 10 DENTAL BONE GRAFT SUBSTITUTES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 60
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES 64
TABLE 12 DENTAL BONE GRAFT SUBSTITUTES MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023−2025 73
TABLE 13 TOP USE CASES AND MARKET POTENTIAL 75
TABLE 14 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 75
TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 18 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 20 CERTIFICATIONS, LABELING, ECO-STANDARDS IN DENTAL BONE GRAFT SUBSTITUTES MARKET 84
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 86
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 87
TABLE 23 DENTAL BONE GRAFT SUBSTITUTES MARKET: UNMET NEEDS/
END-USER EXPECTATIONS 88
TABLE 24 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 91
TABLE 25 SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 92
TABLE 26 XENOGRAFTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 93
TABLE 27 XENOGRAFTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 94
TABLE 28 ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 95
TABLE 29 ALLOGRAFTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 95
TABLE 30 ALLOGRAFTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 96
TABLE 31 DEMINERALIZED BONE MATRIX MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 96
TABLE 32 OTHER ALLOGRAFTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97
TABLE 33 OTHER DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 99
TABLE 34 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 101
TABLE 35 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR SOCKET PRESERVATION,
BY COUNTRY, 2024–2031 (USD MILLION) 102
TABLE 36 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR RIDGE AUGMENTATION,
BY COUNTRY, 2024–2031 (USD MILLION) 103
TABLE 37 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR PERIODONTAL DEFECT REGENERATION, BY COUNTRY, 2024–2031 (USD MILLION) 104
TABLE 38 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR IMPLANT BONE REGENERATION, BY COUNTRY, 2024–2031 (USD MILLION) 105
TABLE 39 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR SINUS LIFT, BY COUNTRY, 2024–2031 (USD MILLION) 107
TABLE 40 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 109
TABLE 41 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR OSTEOCONDUCTION,
BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 42 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR OSTEOINDUCTION,
BY COUNTRY, 2024–2031 (USD MILLION) 111
TABLE 43 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR OSTEOPROMOTION,
BY COUNTRY, 2024–2031 (USD MILLION) 112
TABLE 44 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR OSTEOGENESIS, BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 45 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 116
TABLE 46 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR DENTAL HOSPITALS,
BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 47 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 48 DENTAL BONE GRAFT SUBSTITUTES MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 49 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY REGION,
2024–2031 (USD MILLION) 122
TABLE 50 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 51 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 124
TABLE 52 NORTH AMERICA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 124
TABLE 53 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 125
TABLE 54 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 125
TABLE 55 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031 (USD MILLION) 125
TABLE 56 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 126
TABLE 57 US: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 126
TABLE 58 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 127
TABLE 59 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 127
TABLE 60 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 127
TABLE 61 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 128
TABLE 62 CANADA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128
TABLE 63 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 129
TABLE 64 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 129
TABLE 65 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 129
TABLE 66 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 131
TABLE 67 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 131
TABLE 68 EUROPE: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131
TABLE 69 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 132
TABLE 70 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 132
TABLE 71 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 132
TABLE 72 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 133
TABLE 73 GERMANY: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133
TABLE 74 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 134
TABLE 75 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 134
TABLE 76 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 134
TABLE 77 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 135
TABLE 78 UK: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135
TABLE 79 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 136
TABLE 80 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 136
TABLE 81 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 136
TABLE 82 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 138
TABLE 83 FRANCE: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138
TABLE 84 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 138
TABLE 85 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 139
TABLE 86 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 139
TABLE 87 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 140
TABLE 88 ITALY: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 89 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 140
TABLE 90 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 141
TABLE 91 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 141
TABLE 92 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 142
TABLE 93 SPAIN: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 142
TABLE 94 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 143
TABLE 95 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 143
TABLE 96 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 143
TABLE 97 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 144
TABLE 98 REST OF EUROPE: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144
TABLE 99 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 145
TABLE 100 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 145
TABLE 101 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031 (USD MILLION) 145
TABLE 102 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 103 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 148
TABLE 104 ASIA PACIFIC: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 105 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 148
TABLE 106 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 149
TABLE 107 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 149
TABLE 108 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 150
TABLE 109 JAPAN: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 151
TABLE 110 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 151
TABLE 111 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 151
TABLE 112 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION 152
TABLE 113 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 153
TABLE 114 CHINA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 153
TABLE 115 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 153
TABLE 116 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 154
TABLE 117 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION 154
TABLE 118 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 155
TABLE 119 INDIA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156
TABLE 120 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 156
TABLE 121 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 156
TABLE 122 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION 157
TABLE 123 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 158
TABLE 124 AUSTRALIA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 158
TABLE 125 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 158
TABLE 126 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 159
TABLE 127 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 159
TABLE 128 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 160
TABLE 129 SOUTH KOREA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 160
TABLE 130 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 161
TABLE 131 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 161
TABLE 132 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031 (USD MILLION) 161
TABLE 133 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2024–2031 (USD MILLION) 162
TABLE 134 REST OF ASIA PACIFIC: ALLOGRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 162
TABLE 135 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 163
TABLE 136 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY MECHANISM, 2024–2031 (USD MILLION) 163
TABLE 137 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY END USER, 2024–2031 (USD MILLION 163
TABLE 138 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 139 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 165
TABLE 140 LATIN AMERICA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 165
TABLE 141 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 166
TABLE 142 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 166
TABLE 143 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031 (USD MILLION) 166
TABLE 144 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 167
TABLE 145 BRAZIL: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 167
TABLE 146 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 168
TABLE 147 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 168
TABLE 148 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 168
TABLE 149 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 169
TABLE 150 MEXICO: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169
TABLE 151 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 170
TABLE 152 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM,
2024–2031 (USD MILLION) 170
TABLE 153 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 170
TABLE 154 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 171
TABLE 155 ARGENTINA: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 156 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172
TABLE 157 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 172
TABLE 158 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER,
2024–2031 (USD MILLION) 172
TABLE 159 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2024–2031 (USD MILLION) 173
TABLE 160 REST OF LATIN AMERICA: ALLOGRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 173
TABLE 161 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 174
TABLE 162 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY MECHANISM, 2024–2031 (USD MILLION) 174
TABLE 163 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY END USER, 2024–2031 (USD MILLION) 174
TABLE 164 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2024–2031 (USD MILLION) 176
TABLE 165 MIDDLE EAST & AFRICA: ALLOGRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 176
TABLE 166 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 177
TABLE 167 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY MECHANISM, 2024–2031 (USD MILLION) 177
TABLE 168 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET,
BY END USER, 2024–2031 (USD MILLION) 177
TABLE 169 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2024–2031 (USD MILLION) 178
TABLE 170 GCC COUNTRIES: ALLOGRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 179
TABLE 171 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 179
TABLE 172 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2024–2031 (USD MILLION) 179
TABLE 173 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031 (USD MILLION) 180
TABLE 174 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET, JANUARY 2022 - JANUARY 2026 181
TABLE 175 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEGREE OF COMPETITION 184
TABLE 176 DENTAL BONE GRAFT SUBSTITUTES MARKET: REGION FOOTPRINT 191
TABLE 177 DENTAL BONE GRAFT SUBSTITUTES MARKET: TYPE FOOTPRINT 192
TABLE 178 DENTAL BONE GRAFT SUBSTITUTES MARKET: APPLICATION FOOTPRINT 193
TABLE 179 DENTAL BONE GRAFT SUBSTITUTES MARKET: MECHANISM FOOTPRINT 194
TABLE 180 DENTAL BONE GRAFT SUBSTITUTES MARKET: END-USER FOOTPRINT 195
TABLE 181 DENTAL BONE GRAFT SUBSTITUTES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 199
TABLE 182 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025 199
TABLE 183 DENTAL BONE GRAFT SUBSTITUTES MARKET: PRODUCT LAUNCHES,
JANUARY 2022–JANUARY 2026 201
TABLE 184 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEALS,
JANUARY 2020–JANUARY 2026 201
TABLE 185 DENTAL BONE GRAFT SUBSTITUTES MARKET: EXPANSIONS,
JANUARY 2022–JANUARY 2026 202
TABLE 186 DENTAL BONE GRAFT SUBSTITUTES MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–JANUARY 2026 203
TABLE 187 DENTSPLY SIRONA INC.: COMPANY OVERVIEW 204
TABLE 188 DENTSPLY SIRONA INC.: PRODUCTS OFFERED 205
TABLE 189 DENTSPLY SIRONA: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JANUARY 2026 206
TABLE 190 DENTSPLY SIRONA: DEALS, JANUARY 2022–JANUARY 2026 206
TABLE 191 ENVISTA: COMPANY OVERVIEW 208
TABLE 192 ENVISTA: PRODUCTS OFFERED 209
TABLE 193 ENVISTA: DEALS, JANUARY 2022–JANUARY 2026 210
TABLE 194 ENVISTA: EXPANSIONS (JANUARY 2022–JANUARY 2026) 211
TABLE 195 INSTITUT STRAUMANN AG: BUSINESS OVERVIEW 212
TABLE 196 INSTITUT STRAUMANN AG: PRODUCTS OFFERED 213
TABLE 197 INSTITUT STRAUMANN AG: DEALS, JANUARY 2022–JANUARY 2026 214
TABLE 198 INSTITUT STRAUMANN AG: EXPANSIONS, JANUARY 2022–JANUARY 2026 215
TABLE 199 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW 217
TABLE 200 ADVANCED MEDICAL SOLUTIONS GROUP PLC: PRODUCTS OFFERED 218
TABLE 201 ADVANCED MEDICAL SOLUTIONS GROUP PLC: DEALS,
JANUARY 2022–JANUARY 2026 219
TABLE 202 ZIMVIE INC.: BUSINESS OVERVIEW 220
TABLE 203 ZIMVIE, INC.: PRODUCTS OFFERED 221
TABLE 204 ZIMVIE, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JANUARY 2026 222
TABLE 205 ZIMVIE, INC.: DEALS, JANUARY 2022–JANUARY 2026 222
TABLE 206 HENRY SCHEIN, INC.: BUSINESS OVERVIEW 223
TABLE 207 HENRY SCHEIN, INC.: PRODUCTS OFFERED 224
TABLE 208 HENRY SCHEIN, INC.: DEALS, JANUARY 2022–JANUARY 2026 225
TABLE 209 HENRY SCHEIN, INC.: EXPANSIONS, JANUARY 2022–JANUARY 2026 226
TABLE 210 EVERGEN (RTI SURGICAL): COMPANY OVERVIEW 227
TABLE 211 EVERGEN (RTI SURGICAL): PRODUCTS OFFERED 227
TABLE 212 EVERGEN (RTI SURGICAL): DEALS, JANUARY 2022–JANUARY 2026 228
TABLE 213 EVERGEN (RTI SURGICAL): OTHER DEVELOPMENTS,
JANUARY 2022- JANUARY 2026 228
TABLE 214 LIFENET HEALTH: COMPANY OVERVIEW 229
TABLE 215 LIFENET HEALTH: PRODUCTS OFFERED 229
TABLE 216 LIFENET HEALTH: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JANUARY 2026 230
TABLE 217 LIFENET HEALTH: DEALS, JANUARY 2022–JANUARY 2026 230
TABLE 218 NOVABONE: COMPANY OVERVIEW 231
TABLE 219 NOVABONE: PRODUCTS OFFERED 231
TABLE 220 NOVABONE: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JANUARY 2026 232
TABLE 221 NOVABONE: DEALS, JANUARY 2022–JANUARY 2026 232
TABLE 222 GEISTLICH PHARMA AG: COMPANY OVERVIEW 233
TABLE 223 GEISTLICH PHARMA AG: PRODUCTS OFFERED 233
TABLE 224 GEISTLICH PHARMA AG: DEALS, JANUARY 2022–JANUARY 2026 234
TABLE 225 GEISTLICH PHARMA AG: OTHER DEVELOPMENTS, JANUARY 2022–JANUARY 2026 234
TABLE 226 DENTAL BONE GRAFT SUBSTITUTES MARKET: RISK ASSESSMENT 260
FIGURE 1 KEY INSIGHTS AND MARKET HIGHLIGHTS 30
FIGURE 2 DENTAL BONE GRAFT SUBSTITUTES MARKET OVERVIEW, 2024–2031 31
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET 32
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF DENTAL BONE GRAFT
SUBSTITUTES MARKET 33
FIGURE 5 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET, 2025 34
FIGURE 6 NORTH AMERICA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 35
FIGURE 7 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET 36
FIGURE 8 XENOGRAFTS SEGMENT ACCOUNTED FOR LARGEST SHARE IN ASIA PACIFIC MARKET IN 2025 37
FIGURE 9 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 38
FIGURE 10 ASIA PACIFIC WILL CONTINUE TO DOMINATE DENTAL BONE GRAFT SUBSTITUTES MARKET DURING FORECAST PERIOD 39
FIGURE 11 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 39
FIGURE 12 DENTAL BONE GRAFT SUBSTITUTES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 13 DENTAL BONE GRAFT SUBSTITUTES MARKET: PORTER’S FIVE FORCES ANALYSIS 49
FIGURE 14 DENTAL BONE GRAFT SUBSTITUTES MARKET: VALUE CHAIN ANALYSIS 54
FIGURE 15 DENTAL BONE GRAFT SUBSTITUTES MARKET: SUPPLY CHAIN ANALYSIS 55
FIGURE 16 DENTAL BONE GRAFT SUBSTITUTES MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 17 DENTAL BONE GRAFT SUBSTITUTES MARKET: INVESTMENT AND FUNDING SCENARIO, 2021–2023 62
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS (JANUARY 2015–DECEMBER 2025) 71
FIGURE 19 TOP PATENT APPLICANT COUNTRIES FOR DENTAL BONE GRAFT SUBSTITUTES,
BY REGION, JANUARY 2015–DECEMBER 2025 72
FIGURE 20 DENTAL BONE GRAFT SUBSTITUTES MARKET: PATENT ANALYSIS,
JANUARY 2015–DECEMBER 2025 72
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE APPLICATIONS 86
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 87
FIGURE 23 DENTAL BONE GRAFT SUBSTITUTES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES, 2026–2031 121
FIGURE 24 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT 123
FIGURE 25 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT 147
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET, 2021-2025 183
FIGURE 27 DENTAL BONE GRAFT SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2025 184
FIGURE 28 EV/EBITDA OF KEY VENDORS 185
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 186
FIGURE 30 DENTAL BONE GRAFT SUBSTITUTES MARKET: BRAND/PRODUCT
COMPARATIVE ANALYSIS 187
FIGURE 31 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX 189
FIGURE 32 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY FOOTPRINT 190
FIGURE 33 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2025 198
FIGURE 34 R&D EXPENDITURE OF KEY PLAYERS IN DENTAL BONE GRAFT SUBSTITUES MARKET, 2023-2025 200
FIGURE 35 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT (2025) 205
FIGURE 36 ENVISTA: COMPANY SNAPSHOT (2025) 209
FIGURE 37 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT (2025) 213
FIGURE 38 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY SNAPSHOT (2025) 218
FIGURE 39 ZIMVIE, INC.: COMPANY SNAPSHOT (2025) 220
FIGURE 40 HENRY SCHEIN, INC.: COMPANY SNAPSHOT (2025) 224
FIGURE 41 RESEARCH DESIGN 246
FIGURE 42 PRIMARY SOURCES 248
FIGURE 43 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 250
FIGURE 44 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 251
FIGURE 45 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 251
FIGURE 46 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 252
FIGURE 47 REVENUE SHARE ANALYSIS ILLUSTRATION: INSTITUT STRAUMANN AG 253
FIGURE 48 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL BONE GRAFT
SUBSTITUTES MARKET (2025) 254
FIGURE 49 BOTTOM-UP APPROACH 254
FIGURE 50 TOP-DOWN APPROACH 255
FIGURE 51 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES ANALYSIS, 2026–2031 256
FIGURE 52 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 257
FIGURE 53 DATA TRIANGULATION METHODOLOGY 258